Sarepta Therapeutics Inc.
SRPT | NASDAQ
$18.32
-$0.30 (-1.61%)
At close: Nov 2, 2026, 4:00 PM ET
$18.85
+$0.23 (+1.24%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.02 | 49.23 | -16.63 | -16.14 | -17.49 | -23.98 |
PEG Ratio | 0.01 | -0.35 | 0.60 | -0.29 | 0.63 | 0.90 |
PS Ratio | 1.03 | 6.08 | 7.17 | 12.16 | 10.43 | 24.61 |
PB Ratio | 1.98 | 7.57 | 10.37 | 29.47 | 7.89 | 17.45 |
P/FCF Ratio | -7.33 | -32.77 | -15.14 | -31.73 | -15.19 | 526.07 |
P/OCF Ratio | -10.98 | -56.18 | -17.78 | -34.87 | -16.51 | 123.67 |
OCF/S Ratio | -9.35 | -10.82 | -40.29 | -34.87 | -63.14 | 19.90 |
Debt / Equity Ratio | 0.91 | 0.88 | 1.63 | 4.20 | 1.24 | 1.44 |
Quick Ratio | 1.48 | 3.18 | 3.45 | 3.80 | 5.34 | 5.42 |
Current Ratio | 2.32 | 4.20 | 3.95 | 4.13 | 5.75 | 5.97 |
Asset Turnover | 0.66 | 0.48 | 0.38 | 0.30 | 0.22 | 0.18 |
Interest Coverage | -67.60 | 11.86 | -12.17 | -10.07 | -7.24 | -9.41 |
Return on Equity | -62.55% | 15.40% | -62.37% | -182.75% | -45.13% | -72.74% |
Return on Assets | -21.30% | 5.94% | -16.42% | -22.49% | -13.30% | -18.57% |
Return on Invested Capital | -29.03% | 6.06% | -9.80% | -21.24% | -16.95% | -21.79% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 59.90% | 83.22% | 87.91% | 85% | 86.17% | 88.26% |
Net Profit Margin | -32.45% | 12.37% | -43.11% | -75.40% | -59.66% | -102.60% |
Pretax Profit Margin | -31.94% | 13.71% | -41.83% | -73.95% | -59.69% | -102.40% |
Operating Profit Margin | -29.92% | 11.47% | -21.54% | -57.47% | -65.50% | -104.46% |
FCF Margin | -13.99% | -18.55% | -47.32% | -38.33% | -68.62% | 4.68% |
EBITDA Margin | -29.48% | 16.66% | -36.49% | -63.76% | -45.22% | -83.94% |
Add to Watchlist
Select watchlists to add or remove SRPT